The authors define the place of immunoscintigraphy (IS), a diagnostic method which differs qualitatively from the usual examination methods (US - ultrasonography, CT - computed tomography) in the management of ovarian cancer when monitoring the response to therapy and for detection of subclinical manifestations of the disease.